E Fund Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$636K	Buy	+6,033	New	+$534K	0.02%	231
2025 Q2	$497K	Buy	8,990 +4,853	+117%	+$233K	0.02%	227
2025 Q1	$200K	Sell	4,137 -71,950	-95%	-$3.01M	0.01%	362
2024 Q4	$2.94M	Buy	76,087 +4,421	+6%	+$193K	0.15%	84
2024 Q3	$3.22M	Buy	+71,666	New	+$2.9M	0.17%	65
2024 Q2	–	Sell	-11,304	Closed	-$327K	–	360
2024 Q1	$327K	Buy	11,304 +2,347	+26%	+$63.9K	0.02%	267
2023 Q4	$205K	Sell	8,957 -9,034	-50%	-$158K	0.01%	279
2023 Q3	$300K	Buy	17,991 +2,637	+17%	+$51.2K	0.02%	210
2023 Q2	$424K	Buy	15,354 +6,641	+76%	+$166K	0.03%	153
2023 Q1	$200K	Sell	8,713 -6,769	-44%	-$114K	0.01%	302
2022 Q4	$169K	Sell	15,482 -8,366	-35%	-$70.6K	0.01%	309
2022 Q3	$201K	Sell	23,848 -12,185	-34%	-$115K	0.02%	305
2022 Q2	$285K	Buy	36,033 +25,593	+245%	+$309K	0.03%	243
2022 Q1	$247K	Buy	+10,440	New	+$294K	0.01%	259